Ocular Therapeutix (OCUL) Net Margin (2014 - 2026)
Ocular Therapeutix's quarterly Net Margin came in at 835.11% in Q1 2026, down 24552.0% year-on-year from N/an in Q1 2025, and down 69.59% quarter-over-quarter from 492.45% in Q4 2025.
Ocular Therapeutix has reported Net Margin for 13 years, with the latest figure at 835.11% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 24552.0% year-over-year to 835.11%; the trailing twelve-month figure through Mar 2026 stood at 558.22% (down 22894.0% YoY), and the FY2025 full-year result was 507.2%, down 24815.0% from the prior year.
- Net Margin for Q1 2026 stood at 835.11%, down from 492.45% in the prior quarter.
- The five-year high for Net Margin was 142.09% in Q3 2023, with the low at 835.11% in Q1 2026.
- Average Net Margin over 5 years is 305.69%, with a median of 214.88% recorded in 2024.
- Year-over-year, Net Margin jumped 15036 bps in 2022 and sank 37472 bps in 2025.
- Tracing OCUL's Net Margin over 5 years: stood at 147.67% in 2022, then fell by 4 bps to 153.65% in 2023, then tumbled by 87 bps to 286.92% in 2024, then slumped by 72 bps to 492.45% in 2025, then sank by 70 bps to 835.11% in 2026.
- The last three Net Margin figures came in at 835.11% (Q1 2026), 492.45% (Q4 2025), and 467.35% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -835.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -835.11% |
| Dec 31, 2025 | -492.45% |
| Sep 30, 2025 | -467.35% |
| Jun 30, 2025 | -499.31% |
| Mar 31, 2025 | -589.60% |
| Dec 31, 2024 | -286.92% |
| Sep 30, 2024 | -282.46% |
| Jun 30, 2024 | -247.86% |
| Mar 31, 2024 | -214.88% |
| Dec 31, 2023 | -153.65% |
| Sep 30, 2023 | -142.09% |
| Jun 30, 2023 | -143.64% |
| Mar 31, 2023 | -177.61% |
| Dec 31, 2022 | -147.67% |
| Sep 30, 2022 | -192.70% |
| Jun 30, 2022 | -175.60% |
| Mar 31, 2022 | -147.86% |
| Dec 31, 2021 | -160.25% |
| Sep 30, 2021 | -174.28% |
| Jun 30, 2021 | -186.70% |
| Mar 31, 2021 | -298.22% |
| Dec 31, 2020 | -218.57% |
| Sep 30, 2020 | -267.44% |
| Jun 30, 2020 | -1,246.72% |
| Mar 31, 2020 | -694.06% |
| Dec 31, 2019 | -1,019.19% |
| Sep 30, 2019 | -2,953.80% |
| Jun 30, 2019 | -3,514.92% |
| Mar 31, 2019 | -4,135.57% |
| Dec 31, 2018 | -3,452.18% |
| Sep 30, 2018 | -3,014.06% |
| Jun 30, 2018 | -2,130.25% |
| Mar 31, 2018 | -4,048.53% |
| Dec 31, 2017 | -2,690.35% |
| Sep 30, 2017 | -2,977.44% |
| Jun 30, 2017 | -4,268.04% |
| Mar 31, 2017 | -3,373.26% |
| Dec 31, 2016 | -2,509.20% |
| Sep 30, 2016 | -2,011.53% |
| Jun 30, 2016 | -2,595.24% |
| Mar 31, 2016 | -2,605.77% |
| Dec 31, 2015 | -2,699.75% |
| Sep 30, 2015 | -28,107.32% |
| Jun 30, 2015 | -2,180.61% |
| Mar 31, 2015 | -3,184.03% |
| Dec 31, 2014 | -1,575.05% |
| Sep 30, 2014 | -5,100.70% |
| Jun 30, 2014 | -6,594.85% |
| Mar 31, 2014 | -25,977.78% |